These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3478596)

  • 1. Patent office decision puts Genentech out in front.
    Ezzell C
    Nature; 1987 Nov 12-18; 330(6144):97. PubMed ID: 3478596
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent patent applications in microRNAs.
    Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
    [No Abstract]   [Full Text] [Related]  

  • 4. Patents and patent office resources in biotechnology.
    Koniarek JP; Coleman KD
    Biotechniques; 1988 Feb; 6(2):148-53. PubMed ID: 3273180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K
    Science; 2006 May; 312(5775):827. PubMed ID: 16690824
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech patents: the world is your oyster--or mouse--or (you name it).
    Alix JE
    Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology and patent term extension issues.
    Raines L
    Food Drug Law J; 1999; 54(2):237-40. PubMed ID: 11758579
    [No Abstract]   [Full Text] [Related]  

  • 8. Genentech awarded critical antibody patent.
    Robertson D
    Nat Biotechnol; 2002 Feb; 20(2):108. PubMed ID: 11821843
    [No Abstract]   [Full Text] [Related]  

  • 9. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology: interferon patent contested.
    Earl C; Beardsley T
    Nature; 1984 Mar 1-7; 308(5954):7. PubMed ID: 6199674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent drop reveals pressures on industry.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
    [No Abstract]   [Full Text] [Related]  

  • 12. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 14. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

  • 15. Roche faces charges over Taq patent claim.
    Abbott A
    Nature; 1996 Aug; 382(6593):660. PubMed ID: 8751427
    [No Abstract]   [Full Text] [Related]  

  • 16. Negotiating the RNAi patent thicket.
    Schmidt C
    Nat Biotechnol; 2007 Mar; 25(3):273-5. PubMed ID: 17344871
    [No Abstract]   [Full Text] [Related]  

  • 17. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 18. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 19. A nail in the coffin for DNA sequence patents?
    Yamanaka M
    Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.